Inivata is a leader in liquid biopsy. Our InVision® platform unlocks essential genomic information from a simple blood test to transform the care of cancer patients.

Inivata Receives Medicare Final Coverage Decision for InVisionFirst-Lung Liquid Biopsy Test in Advanced Non-Small Cell Lung Cancer

About Inivata

Inivata is a global clinical cancer genomics company, with offices and labs in Research Triangle Park, NC, USA and Cambridge, UK.

Find out more
Liquid Biopsy

We are transforming clinical cancer care with liquid biopsy.

Find out more
Our Products

Our world-leading InVision™ liquid biopsy platform unlocks essential genomic information from blood.

Find out more
Upcoming Events

Our team attend a host of scientific and investor events across the world.

Find out more
News

Stay up to date with the exciting new developments as we continue to grow.

Find out more
Contact Us

If you are interested in partnering and collaborating with us, or have a question about our products or technology please get in touch.

Find out more

Patients are at the heart of everything we do
Our first product is for advanced Non-Small Cell lung Cancer and our world-leading tests are already impacting patients' lives.
This is the story of the first patient Inivata tested...